Skip to main content
. 2020 May 29;100(10):5762. doi: 10.2340/00015555-3507

Table III.

Numbers of patients with or without changes of interleukin (IL)-17 and IL-23 from baseline to week 26

IL-17A IL-23
Decrease n (%) No change n (%) Increase n (%) Decrease n (%) No change n (%) Increase n (%)
Herring roe oil, week 26, n = 29 16 (55) 0 (0) 13 (45) 10 (34) 17 (59) 2 (7)
Placebo, week 26, n = 32 13 (41) 1 (3) 18 (56) 8 (25) 17 (53) 7 (22)